25 XP   0   0   10

Carasent ASA
Buy, Hold or Sell?

Let's analyse Carasent together

PenkeI guess you are interested in Carasent ASA. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Carasent ASA. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Carasent ASA

I send you an email if I find something interesting about Carasent ASA.

Quick analysis of Carasent (30 sec.)










What can you expect buying and holding a share of Carasent? (30 sec.)

How much money do you get?

How much money do you get?
kr0.00
When do you have the money?
1 year
How often do you get paid?
5.0%

What is your share worth?

Current worth
kr13.21
Expected worth in 1 year
kr10.98
How sure are you?
55.0%

+ What do you gain per year?

Total Gains per Share
kr-2.23
Return On Investment
-15.6%

For what price can you sell your share?

Current Price per Share
kr14.30
Expected price per share
kr13.96 - kr17.74
How sure are you?
50%

1. Valuation of Carasent (5 min.)




Live pricePrice per Share (EOD)

kr14.30

Intrinsic Value Per Share

kr-11.65 - kr-7.67

Total Value Per Share

kr1.56 - kr5.54

2. Growth of Carasent (5 min.)




Is Carasent growing?

Current yearPrevious yearGrowGrow %
How rich?$86.6m$111.1m-$9.9m-9.9%

How much money is Carasent making?

Current yearPrevious yearGrowGrow %
Making money-$1m$706.7k-$1.7m-167.1%
Net Profit Margin-18.8%17.8%--

How much money comes from the company's main activities?

3. Financial Health of Carasent (5 min.)




4. Comparing to competitors in the Health Information Services industry (5 min.)




  Industry Rankings (Health Information Services)  


Richest
#48 / 120

Most Revenue
#80 / 120

Most Profit
#52 / 120

What can you expect buying and holding a share of Carasent? (5 min.)

Welcome investor! Carasent's management wants to use your money to grow the business. In return you get a share of Carasent.

What can you expect buying and holding a share of Carasent?

First you should know what it really means to hold a share of Carasent. And how you can make/lose money.

Speculation

The Price per Share of Carasent is kr14.30. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Carasent.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Carasent, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr13.21. Based on the TTM, the Book Value Change Per Share is kr-0.56 per quarter. Based on the YOY, the Book Value Change Per Share is kr0.22 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Carasent.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps0.010.1%-0.03-0.2%0.010.1%-0.010.0%0.000.0%
Usd Book Value Change Per Share-0.10-0.7%-0.05-0.4%0.020.1%0.050.4%0.030.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.10-0.7%-0.05-0.4%0.020.1%0.050.4%0.030.2%
Usd Price Per Share1.00-1.32-1.86-1.88-1.01-
Price to Earnings Ratio19.28--14.41-48.32-63.17-90.44-
Price-to-Total Gains Ratio-10.44-1.21--93.97-812.01-423.28-
Price to Book Ratio0.84-1.00-1.35-3.98-2.69-
Price-to-Total Gains Ratio-10.44-1.21--93.97-812.01-423.28-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.29701
Number of shares771
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.050.05
Usd Total Gains Per Share-0.050.05
Gains per Quarter (771 shares)-38.9641.77
Gains per Year (771 shares)-155.85167.07
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-156-1660167157
20-312-3220334324
30-468-4780501491
40-623-6340668658
50-779-7900835825
60-935-94601002992
70-1091-1102011701159
80-1247-1258013371326
90-1403-1414015041493
100-1559-1570016711660

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%6.06.00.050.0%11.09.00.055.0%24.016.00.060.0%36.024.00.060.0%
Book Value Change Per Share1.03.00.025.0%6.06.00.050.0%11.09.00.055.0%22.018.00.055.0%30.027.03.050.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%2.00.038.05.0%2.00.058.03.3%
Total Gains per Share1.03.00.025.0%6.06.00.050.0%11.09.00.055.0%22.018.00.055.0%30.027.03.050.0%

Fundamentals of Carasent

About Carasent ASA

Carasent ASA provides cloud based electronic health record solutions to the health care industry in Sweden, Norway, and internationally. The company offers Webdoc, a cloud-based EHR system; Metodika EPM, a solution designed for mid-to-large-sized organizations; Medrave M4 to give healthcare staff and managers an overview and clear picture of the patient group being treated; Health Profile Institute AB (HPI), an occupational care platform; Ad Curis, a record system with digital services tailored for the specialist healthcare service with clients in rehabilitation, interdisciplinary specialized drug treatment, and mental health care, as well as businesses in care and prevention; and Ad Opus, a journal system for follow-up of participants in measures. It also provides platform services, such as Vårdrummet, Confrere, Ad Voca, electronic letters, SMS services, portal to medical services, and consulting and other services. The company was formerly known as Apptix ASA and changed its name to Carasent ASA in May 2019. Carasent ASA was founded in 1997 and is based in Oslo, Norway.

Fundamental data was last updated by Penke on 2024-04-11 03:25:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Carasent ASA.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Carasent earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Carasent to the Health Information Services industry mean.
  • A Net Profit Margin of 15.9% means that kr0.16 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Carasent ASA:

  • The MRQ is 15.9%. The company is making a huge profit. +2
  • The TTM is -18.8%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ15.9%TTM-18.8%+34.6%
TTM-18.8%YOY17.8%-36.6%
TTM-18.8%5Y-8.6%-10.2%
5Y-8.6%10Y1.3%-9.9%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ15.9%-21.3%+37.2%
TTM-18.8%-20.1%+1.3%
YOY17.8%-29.8%+47.6%
5Y-8.6%-36.1%+27.5%
10Y1.3%-42.2%+43.5%
1.1.2. Return on Assets

Shows how efficient Carasent is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Carasent to the Health Information Services industry mean.
  • 0.9% Return on Assets means that Carasent generated kr0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Carasent ASA:

  • The MRQ is 0.9%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is -0.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.9%TTM-0.8%+1.8%
TTM-0.8%YOY0.6%-1.4%
TTM-0.8%5Y-0.4%-0.4%
5Y-0.4%10Y5.1%-5.5%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9%-6.5%+7.4%
TTM-0.8%-6.0%+5.2%
YOY0.6%-5.4%+6.0%
5Y-0.4%-5.3%+4.9%
10Y5.1%-7.4%+12.5%
1.1.3. Return on Equity

Shows how efficient Carasent is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Carasent to the Health Information Services industry mean.
  • 1.1% Return on Equity means Carasent generated kr0.01 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Carasent ASA:

  • The MRQ is 1.1%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is -0.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ1.1%TTM-0.9%+2.0%
TTM-0.9%YOY0.6%-1.6%
TTM-0.9%5Y-0.6%-0.4%
5Y-0.6%10Y4.2%-4.8%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1%-6.8%+7.9%
TTM-0.9%-6.8%+5.9%
YOY0.6%-6.7%+7.3%
5Y-0.6%-8.4%+7.8%
10Y4.2%-9.6%+13.8%

1.2. Operating Efficiency of Carasent ASA.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Carasent is operating .

  • Measures how much profit Carasent makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Carasent to the Health Information Services industry mean.
  • An Operating Margin of 0.0% means the company generated kr0.00  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Carasent ASA:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM2.8%-2.8%
TTM2.8%YOY20.2%-17.4%
TTM2.8%5Y-2.0%+4.7%
5Y-2.0%10Y7.1%-9.0%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ--22.7%+22.7%
TTM2.8%-16.4%+19.2%
YOY20.2%-22.8%+43.0%
5Y-2.0%-18.4%+16.4%
10Y7.1%-31.6%+38.7%
1.2.2. Operating Ratio

Measures how efficient Carasent is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Health Information Services industry mean).
  • An Operation Ratio of 1.29 means that the operating costs are kr1.29 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Carasent ASA:

  • The MRQ is 1.287. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.202. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.287TTM1.202+0.085
TTM1.202YOY1.000+0.202
TTM1.2025Y0.994+0.209
5Y0.99410Y0.910+0.084
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2871.370-0.083
TTM1.2021.385-0.183
YOY1.0001.389-0.389
5Y0.9941.398-0.404
10Y0.9101.349-0.439

1.3. Liquidity of Carasent ASA.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Carasent is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Health Information Services industry mean).
  • A Current Ratio of 4.69 means the company has kr4.69 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Carasent ASA:

  • The MRQ is 4.694. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.491. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.694TTM5.491-0.798
TTM5.491YOY8.457-2.965
TTM5.4915Y5.673-0.182
5Y5.67310Y7.795-2.122
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ4.6941.811+2.883
TTM5.4911.820+3.671
YOY8.4572.055+6.402
5Y5.6732.589+3.084
10Y7.7952.589+5.206
1.3.2. Quick Ratio

Measures if Carasent is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Carasent to the Health Information Services industry mean.
  • A Quick Ratio of 0.40 means the company can pay off kr0.40 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Carasent ASA:

  • The MRQ is 0.404. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 4.340. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ0.404TTM4.340-3.937
TTM4.340YOY8.381-4.041
TTM4.3405Y5.392-1.051
5Y5.39210Y7.542-2.150
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4041.152-0.748
TTM4.3401.241+3.099
YOY8.3811.723+6.658
5Y5.3922.117+3.275
10Y7.5422.107+5.435

1.4. Solvency of Carasent ASA.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Carasent assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Carasent to Health Information Services industry mean.
  • A Debt to Asset Ratio of 0.13 means that Carasent assets are financed with 12.6% credit (debt) and the remaining percentage (100% - 12.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Carasent ASA:

  • The MRQ is 0.126. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.137. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.126TTM0.137-0.011
TTM0.137YOY0.095+0.042
TTM0.1375Y0.180-0.043
5Y0.18010Y0.263-0.083
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1260.379-0.253
TTM0.1370.381-0.244
YOY0.0950.399-0.304
5Y0.1800.411-0.231
10Y0.2630.453-0.190
1.4.2. Debt to Equity Ratio

Measures if Carasent is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Carasent to the Health Information Services industry mean.
  • A Debt to Equity ratio of 14.5% means that company has kr0.14 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Carasent ASA:

  • The MRQ is 0.145. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.161. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.145TTM0.161-0.016
TTM0.161YOY0.105+0.056
TTM0.1615Y0.235-0.074
5Y0.23510Y0.509-0.274
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1450.584-0.439
TTM0.1610.575-0.414
YOY0.1050.607-0.502
5Y0.2350.709-0.474
10Y0.5090.616-0.107

2. Market Valuation of Carasent ASA

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Carasent generates.

  • Above 15 is considered overpriced but always compare Carasent to the Health Information Services industry mean.
  • A PE ratio of 19.28 means the investor is paying kr19.28 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Carasent ASA:

  • The EOD is 24.929. Based on the earnings, the company is fair priced.
  • The MRQ is 19.281. Based on the earnings, the company is fair priced.
  • The TTM is -14.405. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD24.929MRQ19.281+5.648
MRQ19.281TTM-14.405+33.686
TTM-14.405YOY48.323-62.729
TTM-14.4055Y63.171-77.576
5Y63.17110Y90.443-27.272
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD24.929-1.331+26.260
MRQ19.281-2.188+21.469
TTM-14.405-2.131-12.274
YOY48.323-3.487+51.810
5Y63.171-4.987+68.158
10Y90.443-4.494+94.937
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Carasent ASA:

  • The EOD is -19.825. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -15.333. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -16.430. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-19.825MRQ-15.333-4.492
MRQ-15.333TTM-16.430+1.097
TTM-16.430YOY570.608-587.038
TTM-16.4305Y103.708-120.139
5Y103.70810Y52.600+51.108
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD-19.825-1.376-18.449
MRQ-15.333-1.754-13.579
TTM-16.430-2.377-14.053
YOY570.608-5.605+576.213
5Y103.708-3.847+107.555
10Y52.600-3.463+56.063
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Carasent is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Health Information Services industry mean).
  • A PB ratio of 0.84 means the investor is paying kr0.84 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of Carasent ASA:

  • The EOD is 1.083. Based on the equity, the company is underpriced. +1
  • The MRQ is 0.837. Based on the equity, the company is cheap. +2
  • The TTM is 0.999. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD1.083MRQ0.837+0.245
MRQ0.837TTM0.999-0.161
TTM0.999YOY1.350-0.351
TTM0.9995Y3.981-2.983
5Y3.98110Y2.693+1.288
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD1.0831.760-0.677
MRQ0.8371.837-1.000
TTM0.9991.943-0.944
YOY1.3502.978-1.628
5Y3.9813.997-0.016
10Y2.6934.198-1.505
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Carasent ASA compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.059-0.557-47%0.223-576%0.597-277%0.285-472%
Book Value Per Share--13.21014.514-9%15.250-13%9.159+44%5.137+157%
Current Ratio--4.6945.491-15%8.457-44%5.673-17%7.795-40%
Debt To Asset Ratio--0.1260.137-8%0.095+33%0.180-30%0.263-52%
Debt To Equity Ratio--0.1450.161-10%0.105+38%0.235-38%0.509-72%
Dividend Per Share----0%-0%-0%0.000-100%
Eps--0.143-0.300+309%0.095+50%-0.064+145%0.004+3904%
Free Cash Flow Per Share---0.180-0.239+33%-0.182+1%-0.085-53%-0.062-66%
Free Cash Flow To Equity Per Share---0.180-0.268+49%-0.214+19%0.597-130%0.149-221%
Gross Profit Margin--1.0001.055-5%0.926+8%0.996+0%0.998+0%
Intrinsic Value_10Y_max---7.674--------
Intrinsic Value_10Y_min---11.648--------
Intrinsic Value_1Y_max---0.324--------
Intrinsic Value_1Y_min---0.686--------
Intrinsic Value_3Y_max---1.313--------
Intrinsic Value_3Y_min---2.490--------
Intrinsic Value_5Y_max---2.710--------
Intrinsic Value_5Y_min---4.750--------
Market Cap1034244640.000+23%799912288.0001121120637.455-29%1653164515.335-52%1570494102.416-49%845536508.738-5%
Net Profit Margin--0.159-0.188+218%0.178-11%-0.086+154%0.013+1157%
Operating Margin---0.028-100%0.202-100%-0.0200%0.071-100%
Operating Ratio--1.2871.202+7%1.000+29%0.994+30%0.910+41%
Pb Ratio1.083+23%0.8370.999-16%1.350-38%3.981-79%2.693-69%
Pe Ratio24.929+23%19.281-14.405+175%48.323-60%63.171-69%90.443-79%
Price Per Share14.300+23%11.06014.550-24%20.533-46%20.723-47%11.172-1%
Price To Free Cash Flow Ratio-19.825-29%-15.333-16.430+7%570.608-103%103.708-115%52.600-129%
Price To Total Gains Ratio-13.500-29%-10.4411.209-963%-93.973+800%812.007-101%423.280-102%
Quick Ratio--0.4044.340-91%8.381-95%5.392-93%7.542-95%
Return On Assets--0.009-0.008+187%0.006+63%-0.004+144%0.051-81%
Return On Equity--0.011-0.009+186%0.006+70%-0.006+153%0.042-74%
Total Gains Per Share---1.059-0.557-47%0.223-576%0.597-277%0.285-471%
Usd Book Value--86655324.200101199613.400-14%111176840.150-22%64331600.765+35%35993489.288+141%
Usd Book Value Change Per Share---0.096-0.051-47%0.020-576%0.054-277%0.026-472%
Usd Book Value Per Share--1.1981.316-9%1.383-13%0.831+44%0.466+157%
Usd Dividend Per Share----0%-0%-0%0.000-100%
Usd Eps--0.013-0.027+309%0.009+50%-0.006+145%0.000+3904%
Usd Free Cash Flow---1182909.400-1669582.925+41%-1314016.250+11%-604914.580-49%-433514.432-63%
Usd Free Cash Flow Per Share---0.016-0.022+33%-0.016+1%-0.008-53%-0.006-66%
Usd Free Cash Flow To Equity Per Share---0.016-0.024+49%-0.019+19%0.054-130%0.014-221%
Usd Market Cap93805988.848+23%72552044.522101685641.817-29%149942021.541-52%142443815.089-49%76690161.343-5%
Usd Price Per Share1.297+23%1.0031.320-24%1.862-46%1.880-47%1.013-1%
Usd Profit--940740.400-1053140.375+212%706779.750+33%-224659.365+124%119661.800+686%
Usd Revenue--5922165.8005532337.200+7%4427497.825+34%3151221.845+88%3386380.443+75%
Usd Total Gains Per Share---0.096-0.051-47%0.020-576%0.054-277%0.026-471%
 EOD+4 -4MRQTTM+16 -18YOY+17 -175Y+17 -1610Y+15 -21

3.2. Fundamental Score

Let's check the fundamental score of Carasent ASA based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1524.929
Price to Book Ratio (EOD)Between0-11.083
Net Profit Margin (MRQ)Greater than00.159
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.404
Current Ratio (MRQ)Greater than14.694
Debt to Asset Ratio (MRQ)Less than10.126
Debt to Equity Ratio (MRQ)Less than10.145
Return on Equity (MRQ)Greater than0.150.011
Return on Assets (MRQ)Greater than0.050.009
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Carasent ASA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5073.001
Ma 20Greater thanMa 5011.469
Ma 50Greater thanMa 10011.316
Ma 100Greater thanMa 20011.296
OpenGreater thanClose15.000
Total4/5 (80.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Income before Tax  -9,2598,738-521-50,499-51,02046,738-4,28210,0295,747
Net Income  -7,0345,998-1,036-50,267-51,30346,825-4,47814,85010,372
Net Income from Continuing Operations  -7,0335,997-1,036-50,267-51,30346,825-4,47814,85010,372



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in NOK. All numbers in thousands.

Summary
Total Assets1,093,642
Total Liabilities138,236
Total Stockholder Equity955,406
 As reported
Total Liabilities 138,236
Total Stockholder Equity+ 955,406
Total Assets = 1,093,642

Assets

Total Assets1,093,642
Total Current Assets424,688
Long-term Assets668,954
Total Current Assets
Cash And Cash Equivalents 371,521
Net Receivables 36,548
Total Current Assets  (as reported)424,688
Total Current Assets  (calculated)408,069
+/- 16,619
Long-term Assets
Property Plant Equipment 51,499
Goodwill 405,450
Intangible Assets 212,005
Long-term Assets  (as reported)668,954
Long-term Assets  (calculated)668,954
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities90,484
Long-term Liabilities47,752
Total Stockholder Equity955,406
Total Current Liabilities
Accounts payable 16,301
Other Current Liabilities 492
Total Current Liabilities  (as reported)90,484
Total Current Liabilities  (calculated)16,793
+/- 73,691
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt50,170
Long-term Liabilities  (as reported)47,752
Long-term Liabilities  (calculated)50,170
+/- 2,418
Total Stockholder Equity
Total Stockholder Equity (as reported)955,406
Total Stockholder Equity (calculated)0
+/- 955,406
Other
Capital Stock96,337
Common Stock Shares Outstanding 72,325
Net Invested Capital 955,406
Net Working Capital 334,204
Property Plant and Equipment Gross 55,428



Balance Sheet

Currency in NOK. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-31
> Total Assets 
0
0
0
194,235
219,320
231,433
204,624
196,308
184,448
176,941
194,771
200,164
188,314
204,715
193,828
212,590
224,037
230,117
222,378
224,321
219,675
239,649
239,945
228,205
237,336
235,879
327,559
217,572
179,971
170,312
161,208
50,268
49,902
43,853
66,378
61,775
60,949
108,482
107,921
119,243
116,935
114,583
112,434
136,660
151,054
155,881
444,097
504,949
495,931
899,255
1,315,023
1,300,818
1,335,795
1,352,452
1,357,197
1,370,898
1,405,284
1,337,993
1,334,784
1,093,642
1,093,6421,334,7841,337,9931,405,2841,370,8981,357,1971,352,4521,335,7951,300,8181,315,023899,255495,931504,949444,097155,881151,054136,660112,434114,583116,935119,243107,921108,48260,94961,77566,37843,85349,90250,268161,208170,312179,971217,572327,559235,879237,336228,205239,945239,649219,675224,321222,378230,117224,037212,590193,828204,715188,314200,164194,771176,941184,448196,308204,624231,433219,320194,235000
   > Total Current Assets 
0
0
0
33,629
34,138
34,638
29,628
24,345
21,711
21,989
22,880
22,986
23,583
28,849
28,026
28,787
35,403
37,463
34,014
37,128
39,391
37,411
33,267
38,304
38,774
41,937
204,958
93,029
64,469
56,477
54,407
11,394
9,328
7,425
28,070
61,775
60,949
15,328
15,363
18,815
15,998
16,180
16,405
19,620
20,329
23,754
311,209
237,939
237,091
513,283
923,614
909,465
814,642
800,811
782,874
734,210
724,323
701,500
688,195
424,688
424,688688,195701,500724,323734,210782,874800,811814,642909,465923,614513,283237,091237,939311,20923,75420,32919,62016,40516,18015,99818,81515,36315,32860,94961,77528,0707,4259,32811,39454,40756,47764,46993,029204,95841,93738,77438,30433,26737,41139,39137,12834,01437,46335,40328,78728,02628,84923,58322,98622,88021,98921,71124,34529,62834,63834,13833,629000
       Cash And Cash Equivalents 
0
0
0
11,805
11,198
7,733
6,852
5,679
5,182
5,170
4,620
4,584
4,624
7,951
9,860
13,031
15,118
15,608
13,108
18,865
15,513
13,325
14,851
18,989
12,997
12,256
181,458
68,354
43,043
28,138
32,652
11,307
9,182
7,165
27,887
61,570
60,793
8,061
7,905
8,773
7,175
7,241
8,259
10,928
9,386
9,854
12,313
220,254
217,666
486,770
894,635
882,772
787,946
771,186
750,789
694,832
682,961
654,502
636,667
371,521
371,521636,667654,502682,961694,832750,789771,186787,946882,772894,635486,770217,666220,25412,3139,8549,38610,9288,2597,2417,1758,7737,9058,06160,79361,57027,8877,1659,18211,30732,65228,13843,04368,354181,45812,25612,99718,98914,85113,32515,51318,86513,10815,60815,11813,0319,8607,9514,6244,5844,6205,1705,1825,6796,8527,73311,19811,805000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,321
6,582
9,278
7,638
7,829
6,813
8,131
9,063
11,992
297,124
14,588
17,759
23,816
26,019
20,000
23,295
23,000
26,000
27,575
28,248
33,541
40,594
36,548
36,54840,59433,54128,24827,57526,00023,00023,29520,00026,01923,81617,75914,588297,12411,9929,0638,1316,8137,8297,6389,2786,5826,3210000000000000000000000000000000000000
       Other Current Assets 
0
0
0
3,419
3,147
3,417
3,137
3,169
2,747
2,896
2,890
2,692
2,534
2,128
2,076
1,491
1,563
1,634
1,394
1,490
1,459
1,012
1,038
1,160
1,203
1,754
1,364
1,327
1,189
1,853
2,424
86
146
260
183
-8
156
7,267
-1
-1
8,823
1
-1
-1
-1
1
298,896
1
19,425
26,513
28,979
26,693
-1
1
1
0
0
-1
0
0
00-10011-126,69328,97926,51319,4251298,8961-1-1-118,823-1-17,267156-8183260146862,4241,8531,1891,3271,3641,7541,2031,1601,0381,0121,4591,4901,3941,6341,5631,4912,0762,1282,5342,6922,8902,8962,7473,1693,1373,4173,1473,419000
   > Long-term Assets 
0
0
0
160,606
185,182
196,795
174,996
171,964
162,737
154,952
171,890
177,178
164,730
175,866
165,803
183,803
188,634
192,654
188,364
187,192
180,284
202,238
206,678
189,900
198,562
193,943
122,602
124,543
115,502
113,835
106,801
38,874
40,575
36,428
38,308
0
0
93,154
92,558
100,428
100,937
98,403
96,029
117,040
130,725
132,127
132,888
267,011
258,839
385,972
391,409
391,354
521,153
551,641
574,323
636,688
680,961
636,492
646,589
668,954
668,954646,589636,492680,961636,688574,323551,641521,153391,354391,409385,972258,839267,011132,888132,127130,725117,04096,02998,403100,937100,42892,55893,1540038,30836,42840,57538,874106,801113,835115,502124,543122,602193,943198,562189,900206,678202,238180,284187,192188,364192,654188,634183,803165,803175,866164,730177,178171,890154,952162,737171,964174,996196,795185,182160,606000
       Property Plant Equipment 
0
0
0
26,542
44,904
45,504
39,316
36,496
32,969
30,464
38,273
40,307
34,820
39,822
35,345
57,568
57,047
56,067
53,478
51,901
46,718
66,415
64,445
69,345
69,154
66,024
36,297
35,496
31,761
29,488
25,887
0
0
0
0
0
0
0
0
678
4,054
1,123
937
17,652
18,679
17,649
16,763
17,115
15,010
19,355
17,754
16,118
16,875
22,629
20,462
40,024
40,141
37,305
52,393
51,499
51,49952,39337,30540,14140,02420,46222,62916,87516,11817,75419,35515,01017,11516,76317,64918,67917,6529371,1234,0546780000000025,88729,48831,76135,49636,29766,02469,15469,34564,44566,41546,71851,90153,47856,06757,04757,56835,34539,82234,82040,30738,27330,46432,96936,49639,31645,50444,90426,542000
       Goodwill 
0
0
0
125,815
0
0
0
127,266
0
0
0
0
0
0
0
120,864
0
0
0
131,655
0
0
0
118,712
0
0
0
87,614
0
0
0
0
0
0
0
0
0
56,520
56,550
61,535
16,103
57,117
57,601
58,813
64,851
64,842
65,404
170,339
165,909
275,878
275,675
271,990
366,036
372,646
374,504
385,181
404,581
399,051
394,430
405,450
405,450394,430399,051404,581385,181374,504372,646366,036271,990275,675275,878165,909170,33965,40464,84264,85158,81357,60157,11716,10361,53556,55056,52000000000087,614000118,712000131,655000120,8640000000127,266000125,815000
       Intangible Assets 
0
0
0
8,249
140,278
151,291
135,680
8,201
129,769
124,488
133,618
0
129,911
136,043
0
5,371
0
0
0
3,637
0
0
0
1,844
0
0
0
1,433
0
0
0
0
0
0
0
0
0
35,907
35,320
38,216
80,779
40,162
37,491
40,576
47,195
49,636
50,721
78,440
76,803
89,622
96,864
102,919
137,915
156,367
179,357
211,483
236,240
200,137
199,767
212,005
212,005199,767200,137236,240211,483179,357156,367137,915102,91996,86489,62276,80378,44050,72149,63647,19540,57637,49140,16280,77938,21635,32035,9070000000001,4330001,8440003,6370005,3710136,043129,9110133,618124,488129,7698,201135,680151,291140,2788,249000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
727
688
-1
1
2
-1
0
-1
2
0
-1
1
1,118
1,116
-1
327
-1
0
1
0
1
0
0
001010-1327-11,1161,1181-102-10-121-16887270000000000000000000000000000000000000
> Total Liabilities 
0
0
0
72,804
98,668
105,768
95,936
89,718
82,896
78,037
85,896
86,130
78,615
87,900
78,565
97,744
101,200
101,245
93,704
93,529
90,037
106,948
99,246
146,303
147,063
144,603
172,500
146,106
111,245
99,233
89,581
1,219
608
863
3,058
509
2,635
24,573
23,877
27,811
27,020
25,035
21,897
46,083
50,182
60,723
83,700
103,973
110,618
124,245
145,128
129,543
122,869
127,643
118,476
144,296
155,085
145,509
269,825
138,236
138,236269,825145,509155,085144,296118,476127,643122,869129,543145,128124,245110,618103,97383,70060,72350,18246,08321,89725,03527,02027,81123,87724,5732,6355093,0588636081,21989,58199,233111,245146,106172,500144,603147,063146,30399,246106,94890,03793,52993,704101,245101,20097,74478,56587,90078,61586,13085,89678,03782,89689,71895,936105,76898,66872,804000
   > Total Current Liabilities 
0
0
0
44,378
75,559
84,235
79,451
51,928
49,793
48,111
50,757
51,523
75,466
81,433
72,542
48,596
53,248
54,274
47,897
47,418
74,884
78,097
75,848
123,463
89,599
91,756
117,390
94,664
72,750
64,009
57,847
1,219
608
863
3,058
509
2,635
14,021
13,269
17,331
15,591
16,730
16,872
21,010
22,949
26,222
38,200
41,158
39,168
64,860
58,673
109,047
95,735
94,867
86,378
93,985
105,566
98,216
210,639
90,484
90,484210,63998,216105,56693,98586,37894,86795,735109,04758,67364,86039,16841,15838,20026,22222,94921,01016,87216,73015,59117,33113,26914,0212,6355093,0588636081,21957,84764,00972,75094,664117,39091,75689,599123,46375,84878,09774,88447,41847,89754,27453,24848,59672,54281,43375,46651,52350,75748,11149,79351,92879,45184,23575,55944,378000
       Short-term Debt 
0
0
0
14,454
38,038
40,940
44,540
18,983
17,780
16,385
19,624
20,873
44,598
46,468
41,138
18,497
18,419
18,914
17,097
16,664
43,901
49,123
53,461
64,460
30,235
29,382
29,415
28,543
34,488
27,014
21,908
0
0
0
0
0
0
0
0
0
1,444
966
409
3,458
3,918
4,214
4,560
5,746
5,061
6,167
5,817
5,703
6,428
7,932
7,938
10,033
10,646
9,976
12,135
0
012,1359,97610,64610,0337,9387,9326,4285,7035,8176,1675,0615,7464,5604,2143,9183,4584099661,44400000000021,90827,01434,48828,54329,41529,38230,23564,46053,46149,12343,90116,66417,09718,91418,41918,49741,13846,46844,59820,87319,62416,38517,78018,98344,54040,94038,03814,454000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
930
643
278
851
742
730
736
943
586
302
0
0
0
0
0
968
1,034
501
330
0
03305011,034968000003025869437367307428512786439300000000000000000000000000000000000000000
       Accounts payable 
0
0
0
12,377
15,042
22,377
15,411
13,333
11,397
10,893
9,333
8,506
7,461
8,655
6,482
7,292
10,839
10,438
7,563
6,963
11,801
8,781
9,630
11,346
11,393
14,097
9,746
16,816
9,445
10,492
11,542
510
34
8
1,978
8
407
3,043
4,853
3,343
2,234
2,396
2,056
1,917
2,254
2,084
14,927
4,883
3,503
15,230
6,735
8,942
10,119
10,734
10,569
20,245
13,384
9,252
14,940
16,301
16,30114,9409,25213,38420,24510,56910,73410,1198,9426,73515,2303,5034,88314,9272,0842,2541,9172,0562,3962,2343,3434,8533,04340781,97883451011,54210,4929,44516,8169,74614,09711,39311,3469,6308,78111,8016,9637,56310,43810,8397,2926,4828,6557,4618,5069,33310,89311,39713,33315,41122,37715,04212,377000
       Other Current Liabilities 
0
0
0
17,547
22,479
20,918
19,500
19,612
20,616
20,834
21,800
22,144
23,407
26,310
24,923
22,807
23,990
24,923
23,237
23,791
19,182
20,193
12,756
47,657
47,971
48,277
78,229
20,842
28,817
26,503
24,397
709
574
855
1,080
501
2,228
10,978
8,416
13,988
1,335
1,521
1,805
1,823
2,583
3,467
2,642
8,759
2,503
3,853
6,003
6,631
2,997
76,201
67,871
63,707
81,536
4,880
119,651
492
492119,6514,88081,53663,70767,87176,2012,9976,6316,0033,8532,5038,7592,6423,4672,5831,8231,8051,5211,33513,9888,41610,9782,2285011,08085557470924,39726,50328,81720,84278,22948,27747,97147,65712,75620,19319,18223,79123,23724,92323,99022,80724,92326,31023,40722,14421,80020,83420,61619,61219,50020,91822,47917,547000
   > Long-term Liabilities 
0
0
0
28,426
23,109
21,533
16,485
37,790
33,103
29,926
35,138
34,607
3,149
6,467
6,023
49,149
47,952
46,971
45,807
46,111
15,152
28,851
23,398
22,840
57,464
52,848
55,110
51,442
38,495
35,225
31,734
0
0
0
0
0
0
10,552
10,608
10,480
11,429
8,305
5,025
25,073
27,233
34,501
45,500
62,815
71,450
59,385
86,455
20,496
27,134
32,776
32,098
50,311
49,519
47,293
59,186
47,752
47,75259,18647,29349,51950,31132,09832,77627,13420,49686,45559,38571,45062,81545,50034,50127,23325,0735,0258,30511,42910,48010,60810,55200000031,73435,22538,49551,44255,11052,84857,46422,84023,39828,85115,15246,11145,80746,97147,95249,1496,0236,4673,14934,60735,13829,92633,10337,79016,48521,53323,10928,426000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,553
7,566
7,254
6,660
6,378
7,696
9,787
11,326
19,738
31,780
50,053
60,455
45,668
74,159
9,863
16,716
18,616
19,937
22,126
0
21,968
19,200
0
019,20021,968022,12619,93718,61616,7169,86374,15945,66860,45550,05331,78019,73811,3269,7877,6966,3786,6607,2547,5667,5530000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
50,735
0
0
0
0
0
0
0
0
0000000050,735000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
121,431
120,652
125,665
108,688
106,590
101,552
98,904
108,875
114,034
109,699
116,815
115,263
114,846
122,838
128,872
128,674
130,791
129,638
132,702
140,699
81,902
90,273
91,276
155,059
71,466
68,726
71,079
71,628
49,049
49,294
42,990
63,320
61,266
58,314
83,909
84,044
91,432
89,915
89,548
90,537
90,577
100,872
95,158
360,397
400,976
385,313
775,010
1,169,895
1,171,275
1,212,926
1,224,809
1,238,721
1,226,602
1,250,199
1,192,484
1,064,959
955,406
955,4061,064,9591,192,4841,250,1991,226,6021,238,7211,224,8091,212,9261,171,2751,169,895775,010385,313400,976360,39795,158100,87290,57790,53789,54889,91591,43284,04483,90958,31461,26663,32042,99049,29449,04971,62871,07968,72671,466155,05991,27690,27381,902140,699132,702129,638130,791128,674128,872122,838114,846115,263116,815109,699114,034108,87598,904101,552106,590108,688125,665120,652121,431000
   Common Stock
0
0
0
27,116
27,116
27,116
27,116
27,431
26,055
25,074
27,082
27,850
26,573
27,812
26,764
26,051
27,309
28,349
28,031
28,377
28,022
28,612
30,076
34,691
37,411
36,705
39,542
41,016
38,794
39,133
37,582
40,335
39,966
39,102
37,061
38,315
27,116
54,124
54,124
54,124
54,124
54,124
54,124
54,124
54,124
54,124
54,124
73,307
73,307
88,752
104,719
104,719
105,892
105,892
105,892
106,055
106,055
106,055
106,055
0
0106,055106,055106,055106,055105,892105,892105,892104,719104,71988,75273,30773,30754,12454,12454,12454,12454,12454,12454,12454,12454,12454,12427,11638,31537,06139,10239,96640,33537,58239,13338,79441,01639,54236,70537,41134,69130,07628,61228,02228,37728,03128,34927,30926,05126,76427,81226,57327,85027,08225,07426,05527,43127,11627,11627,11627,116000
   Retained Earnings Total Equity000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 000000000000-8710000000-14400000000000-182,955000-140,444000-108,739000-81,079000-79,642000-65,1440000000
   Capital Surplus 000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
432,488
456,916
458,509
458,999
552,170
441,066
424,886
459,249
575,727
451,393
472,784
455,260
546,390
487,991
482,970
501,310
616,378
501,406
488,012
513,085
761,542
638,372
626,376
674,831
828,561
578,009
583,072
559,965
508,757
463,015
452,996
429,357
443,882
34,149
35,819
35,918
35,963
35,818
35,819
35,819
35,819
35,819
35,819
309,473
364,830
355,970
710,289
1,110,616
1,102,996
1,118,085
1,127,564
1,131,064
1,125,816
1,150,450
1,144,037
1,020,990
0
01,020,9901,144,0371,150,4501,125,8161,131,0641,127,5641,118,0851,102,9961,110,616710,289355,970364,830309,47335,81935,81935,81935,81935,81935,81835,96335,91835,81934,149443,882429,357452,996463,015508,757559,965583,072578,009828,561674,831626,376638,372761,542513,085488,012501,406616,378501,310482,970487,991546,390455,260472,784451,393575,727459,249424,886441,066552,170458,999458,509456,916432,488000



Balance Sheet

Currency in NOK. All numbers in thousands.




Cash Flow

Currency in NOK. All numbers in thousands.




Income Statement

Currency in NOK. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue243,984
Cost of Revenue-46,216
Gross Profit197,768197,768
 
Operating Income (+$)
Gross Profit197,768
Operating Expense-281,538
Operating Income-37,554-83,770
 
Operating Expense (+$)
Research Development0
Selling General Administrative57,786
Selling And Marketing Expenses0
Operating Expense281,53857,786
 
Net Interest Income (+$)
Interest Income17,394
Interest Expense-2,093
Other Finance Cost-12,144
Net Interest Income27,445
 
Pretax Income (+$)
Operating Income-37,554
Net Interest Income27,445
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-50,077-37,554
EBIT - interestExpense = -2,093
-46,445
-44,352
Interest Expense2,093
Earnings Before Interest and Taxes (EBIT)0-47,984
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-50,077
Tax Provision--3,632
Net Income From Continuing Ops-46,445-46,445
Net Income-46,445
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-27,445
 

Technical Analysis of Carasent
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Carasent. The general trend of Carasent is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Carasent's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Carasent ASA.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 15.86 < 15.88 < 17.74.

The bearish price targets are: 14.31 > 14.31 > 13.96.

Tweet this
Carasent ASA Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Carasent ASA. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Carasent ASA Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Carasent ASA. The current macd is 0.60545307.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Carasent price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Carasent. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Carasent price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Carasent ASA Daily Moving Average Convergence/Divergence (MACD) ChartCarasent ASA Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Carasent ASA. The current adx is 21.51.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Carasent shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Carasent ASA Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Carasent ASA. The current sar is 10.84.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Carasent ASA Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Carasent ASA. The current rsi is 73.00. The current phase is Overbought in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Overbought in bull market: Short-term excessive buying, potential for pullback. Consider taking profits, be cautious of potential correction. -1
  • Trending down: The RSI is trending down. -1
Carasent ASA Daily Relative Strength Index (RSI) ChartCarasent ASA Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Carasent ASA. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Carasent price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Carasent ASA Daily Stochastic Oscillator ChartCarasent ASA Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Carasent ASA. The current cci is 212.20.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Carasent ASA Daily Commodity Channel Index (CCI) ChartCarasent ASA Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Carasent ASA. The current cmo is 52.47.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Carasent ASA Daily Chande Momentum Oscillator (CMO) ChartCarasent ASA Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Carasent ASA. The current willr is -28.44036697.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Carasent is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Carasent ASA Daily Williams %R ChartCarasent ASA Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Carasent ASA.

Carasent ASA Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Carasent ASA. The current atr is 0.78206216.

Carasent ASA Daily Average True Range (ATR) ChartCarasent ASA Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Carasent ASA. The current obv is 1,452,340.

Carasent ASA Daily On-Balance Volume (OBV) ChartCarasent ASA Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Carasent ASA. The current mfi is 67.42.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Carasent ASA Daily Money Flow Index (MFI) ChartCarasent ASA Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Carasent ASA.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-04BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-05ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-11MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-16RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-29MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-15MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-25WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-26STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside

6.3. Candlestick Patterns

Carasent ASA Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Carasent ASA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5073.001
Ma 20Greater thanMa 5011.469
Ma 50Greater thanMa 10011.316
Ma 100Greater thanMa 20011.296
OpenGreater thanClose15.000
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Carasent with someone you think should read this too:
  • Are you bullish or bearish on Carasent? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Carasent? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Carasent ASA

I send you an email if I find something interesting about Carasent ASA.


Comments

How you think about this?

Leave a comment

Stay informed about Carasent ASA.

Receive notifications about Carasent ASA in your mailbox!